![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Susana Barbosa-Méndez, Gilberto Perez-Sánchez & Alberto Salazar-Juárez. (2023) Agomelatine decreases cocaine-induced locomotor sensitisation and dopamine release in rats. The World Journal of Biological Psychiatry 24:5, pages 400-413.
Read now
Read now
Mahesh Shinde, Nikhil Bali, Shahadev Rathod, Megha Karemore & Pramod Salve. (2020) Effect of binary combinations of solvent systems on permeability profiling of pure agomelatine across rat skin: a comparative study with statistically optimized polymeric nanoparticles. Drug Development and Industrial Pharmacy 46:5, pages 826-845.
Read now
Read now
D. Guenzani, M. Buoli, G. S. Carnevali, M. Serati, P. Messa & S. Vettoretti. (2018) Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure?. Psychology, Health & Medicine 23:8, pages 970-979.
Read now
Read now
Massimiliano Buoli, Silvia Grassi, Marta Serati & A. Carlo Altamura. (2017) Agomelatine for the treatment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 18:13, pages 1373-1379.
Read now
Read now
Alfredo Carlo Altamura, Alice Caldiroli & Massimiliano Buoli. (2015) Pharmacokinetic evaluation of fluvoxamine for the treatment of anxiety disorders. Expert Opinion on Drug Metabolism & Toxicology 11:4, pages 649-660.
Read now
Read now
Articles from other publishers (11)
Miłosz Nesterowicz, Kamil Klaudiusz Lauko, Małgorzata Żendzian-Piotrowska, Jerzy Robert Ładny, Anna Zalewska & Mateusz Maciejczyk. (2023) Agomelatine's antiglycoxidative action—In vitro and in silico research and systematic literature review. Frontiers in Psychiatry 14.
Crossref
Crossref
Mohamed Ettaoussi, Amélie Laversin, Brandon Vreulz, Marouane Rami, Nicolas Lebegue, Philippe Delagrange, Daniel Henri Caignard, Patricia Melnyk, Maxime Liberelle & Saïd Yous. (2021) Synthesis and SAR Studies of Isoquinoline and Tetrahydroisoquinoline Derivatives as Melatonin Receptor Ligands. ChemMedChem 17:3.
Crossref
Crossref
Cheng-Chen Chang, Yen-Jen Chen, Yu-An Chen & Yi-Cheng Liao. (2021) Acute Hepatitis Due to Agomelatine Use in Elderly Women with Depression: Case Series. Clinical Psychopharmacology and Neuroscience 19:4, pages 789-792.
Crossref
Crossref
Philip Gorwood, Jacques Benichou, Nicolas Moore, Marine Wattez, Marie-Cécile Secouard, Xavier Desobry, Françoise Picarel-Blanchot & Christian de Bodinat. (2020) Agomelatine in Standard Medical Practice in Depressed Patients: Results of a 1-Year Multicentre Observational Study In France. Clinical Drug Investigation 40:11, pages 1009-1020.
Crossref
Crossref
Yu. P. Sivolap. (2018) Antidepressants: the goals and possibilities of therapy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:12, pages 120.
Crossref
Crossref
Panagiotis Barmpalexis, Agni Grypioti, Elisavet Vardaka, Anna Karagianni & Kyriakos Kachrimanis. (2018) Development of a Novel Amorphous Agomelatine Formulation With Improved Storage Stability and Enhanced Bioavailability. Journal of Pharmaceutical Sciences 107:1, pages 257-266.
Crossref
Crossref
Marina Dyskant Mochcovitch, Rafael Christophe da Rocha Freire, Rafael Ferreira Garcia & Antonio Egidio Nardi. (2017) Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review. Clinical Drug Investigation 37:8, pages 737-743.
Crossref
Crossref
Gerd Laux, Bettina Barthel, Göran Hajak, Matthias Lemke & Hans-Peter Volz. (2017) Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily Practice. Advances in Therapy 34:4, pages 895-914.
Crossref
Crossref
Cuiyun Li, Jing Xu, Yan Zheng, Guiling Chen, Jianmeng Wang, Liying Ma, Yan Qiao, Junqi Niu, Min Wu, Hong Zhang, Xiaojiiao Li, Hong Chen, Xiaoxue Zhu, Chengjiao Liu & Yanhua Ding. (2017) Bioequivalence and Pharmacokinetic Profiles of Agomelatine 25-mg Tablets in Healthy Chinese Subjects: A Four-Way Replicate Crossover Study Demonstrating High Intra- and Inter-Individual Variations. CHEMICAL & PHARMACEUTICAL BULLETIN Chemical and Pharmaceutical Bulletin 65:6, pages 524-529.
Crossref
Crossref
Domenico De Berardis, Michele Fornaro, Nicola Serroni, Daniela Campanella, Gabriella Rapini, Luigi Olivieri, Venkataramanujam Srinivasan, Felice Iasevoli, Carmine Tomasetti, Andrea De Bartolomeis, Alessandro Valchera, Giampaolo Perna, Monica Mazza, Marco Di Nicola, Giovanni Martinotti & Massimo Di Giannantonio. (2015) Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression. International Journal of Molecular Sciences 16:1, pages 1111-1130.
Crossref
Crossref
Maria S Signorelli, Carmen Concerto, Eliana Battaglia, Maria C Costanzo, Fortunato Battaglia & Eugenio Aguglia. (2014) Venlafaxine augmentation with agomelatine in a patient with obsessive-compulsive disorder and suicidal behaviors. SAGE Open Medical Case Reports 2, pages 2050313X1456177.
Crossref
Crossref